scorecardresearch
Add as a preferred source on Google
Thursday, April 30, 2026
TopicObesity

Topic: Obesity

Genes decide who responds better to GLP-1 drugs. How Nature study findings can change obesity treatment

The study finds specific genetic variants that predict how much weight a person will lose on taking weight loss drugs, & the severity of side effects they experience.

Why do weight loss drugs work for some and not for others? New study finds

A study, published in Nature, investigated drugs such as semaglutide and tirzepatide, which have gained global attention for their effectiveness in reducing body weight.

FSSAI has failed to resolve diet-related issues in India—public health crisis on the rise

The key question before us is simple: Whose interest should guide food policy in India? The credibility of India's food regulatory system depends on the answer to this question.

A 5-spice mix to fight long-term diabetes & obesity complications? ICMR set to back human trials

Looking beyond blood sugar control, ICMR-NIN scientists have combined 5 regular kitchen spices in precise proportions, 'marking a shift toward integrative health solutions'.

FSSAI seeks more time from SC to work on front-of-pack labels for foods with high fat, sugar & salt

Food regulator FSSAI weighs pictures versus labels on packaged food amid growing pressure for long-overdue health reform.

India braces for cheaper anti-obesity drugs as Ozempic patent expires

With semaglutide patent ending, Indian pharma firms are set to launch lower-cost versions, prompting hospitals and clinics to expand obesity services ahead of a surge in demand.

As semaglutide goes off patent, weight-loss gold rush begins. Pharma bets big, court case lingers

Several leading Indian drugmakers have already secured regulatory approval or recommendations to produce and market generic versions of the weight loss drugs in India.

3 popular GLP-1 drugs may work on rare & hard-to-treat genetic obesity, Japanese researchers find

Children with certain genetic defects affecting hunger control can become severely obese from the age of one or two. Findings suggest that medicines based on GLP-1 hormone may work.

Supriya Pathak and Ratna Pathak Shah tackle obesity stigma in new ad. ‘It’s not a joke’

The ad by Lilly India is opening the door to a weight loss conversation. It features links to research papers from the World Health Organisation and Columbia University.

Lancet study links obesity to 1 in 10 infection deaths globally. What it means for India

Study analysed data from over 540,000 adults in Finland and the UK. To study worldwide estimates, the researchers then used global data from the Global Burden of Diseases (GBD) Study.

On Camera

New promo video by PLA Navy is a teaser of China’s deep blue capabilities

Rather than functioning as conventional propaganda, the video operates as a device for interpretation, subtly shaping expectations about future developments in China’s naval trajectory.

Adani’s giant copper plant hits technical setbacks in first year

The 500,000 tonne-per-year plant produced just 94,000 tonnes of refined copper from April 2025 to February this year.

Indian drone tech company ideaForge signs MoU with Japanese firm to develop next-gen AI powered drones

By pairing Indian drone engineering with Japanese semiconductor expertise, the two firms aim to develop more advanced autonomous systems tailored to both defence & commercial use.

Trump, Netanyahu’s Iran gamble: The regime change rebound

American objectives are unmet. They neither have muscle nor motivation to resume the war. As for Iran, the regime didn’t just survive, it’s now led by more radical individuals.